Home › Funds › 683 Capital Management, LLC › SRPT
683 Capital Management, LLC position in SRPT
SAREPTA THERAPEUTICS INC · Health Care
683 Capital Management, LLC reported holding 782,500 shares of SRPT (SAREPTA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$14.1M, representing 0.75% of its reported portfolio and ranking #30 among its reported holdings. 683 Capital Management, LLC has disclosed SRPT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How 683 Capital Management, LLC's SRPT position evolved
683 Capital Management, LLC first disclosed a stake in SRPT in Q3 2023 at 20,000 shares (US$2.4M). The position peaked in Q3 2025 at 990,000 shares, worth US$19.1M. Across 12 filings, 683 Capital Management, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 782,500 shares valued at US$14.1M — an increase of 32,500 shares quarter over quarter.. Notable position changes include a 333% increase in Q4 2023 (shares rose 34% over the following quarter), a 62% increase in Q1 2025 (shares fell 73% over the following quarter), a 309% increase in Q2 2025 (shares rose 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 20.00K | $2.42M | New |
| Q4 2023 | 86.60K | $8.35M | Add |
| Q1 2024 | 62.83K | $8.13M | Reduce |
| Q2 2024 | 63.50K | $10.03M | Add |
| Q3 2024 | 87.22K | $10.89M | Add |
| Q4 2024 | 102.00K | $12.40M | Add |
| Q1 2025 | 165.00K | $10.53M | Add |
| Q2 2025 | 675.00K | $11.54M | Add |
| Q3 2025 | 990.00K | $19.08M | Add |
| Q4 2025 | 810.00K | $17.43M | Reduce |
| Q1 2026 | 750.00K | $16.32M | Reduce |
| Q2 2026 | 782.50K | $14.06M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRPT and 13F data
SRPT (SAREPTA THERAPEUTICS INC) is a Health Care company. 12 other funds we track also report a position in SRPT — the largest reported positions include HIGHBRIDGE CAPITAL MANAGEMENT LLC (US$49.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRPT
- HIGHBRIDGE CAPITAL MANAGEMENT LLC 52.31M sh · $49.27M · Q2 2026
More on 683 Capital Management, LLC
FAQ
How long has 683 Capital Management, LLC held SRPT?
683 Capital Management, LLC has disclosed SRPT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is 683 Capital Management, LLC's current position in SRPT?
As of Q2 2026, 683 Capital Management, LLC holds 782.50K shares of SRPT (SAREPTA THERAPEUTICS INC), valued at $14.06M, representing 0.75% of its reported portfolio and ranking #30.
Has 683 Capital Management, LLC been buying or selling SRPT?
In the latest 13F filing (Q2 2026), 683 Capital Management, LLC increased its position in SRPT. The position peaked in Q3 2025 at 990.00K shares.
Which other funds hold SRPT?
Other major institutional holders of SRPT include HIGHBRIDGE CAPITAL MANAGEMENT LLC, among 12 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.